PhD, Risk Economics
Jorien Veldwijk joined CRB in October 2015. She holds a Masters’ degree in Public Heath as well as in Clinical Epidemiology. Before starting her PhD she worked as a researcher at the Dutch National Institute for Public Health and the Environment. During that time she was involved in several research projects regarding the consequences of overweight among children, partly in collaboration with the World Health Organization. During her PhD she used Discrete Choice Experiments (DCEs) to determine individuals’ preferences and their decision-making behavior regarding public health initiatives. She obtained her PhD in May 2015 and was appointed assistant professor at the University Medical Center Utrecht where her research continued to be focused on behavioral economics. Currently she continues working in the same research field using DCEs both at CRB and as a Senior Researcher at the Erasmus Medical Centre.
Phone: +46 18-471 65 66
- Åsa Grauman: Self-perceived risk for cardiovascular diseases and preferences for risk information
- Karin Schölin Bywall: The value of patient preferences in drug development for rheumatoid arthritis
We are investigating risk information from serval perspectives.
Managing genetic risk information
Research generates huge amounts of genetic information. How should we handle it? That is what we are trying to find out in a large international research project.
Giving patients a voice in drug development
PREFER is a five year public-private research project where academic researchers and the pharmaceutical industry work together to find out when and where patients want, can and should be involved in drug development
Karin Schölin Bywall will look at how rheumatoid arthritis patient preferences can provide added value in regulatory decision making in the drug development process.
Mirko Ancillotti is looking at antibiotics resistance and the ethical aspects of using peptide-based antibiotics.
Handling incidental findings
How should we handle incidental findings in biobank and -omics research? Jennifer Viberg Johansson is looking at the arguments for and against disclosure of incidental findings.
Cardiovascular risk information
Åsa Grauman will investigate how research participants perceive their personal risk for cardiovascular disease, and their perceptions on cardiovascular risk information.
People’s willingness, preferences and public health
What is it that makes people decide not to vaccinate their children or take part in a screening programme? And what would make them consider doing it? With the help of Discrete Choice Experiments, Jorien Veldwijk is trying to find out what people prefer and how willing they are to participate in public health interventions.